These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

458 related items for PubMed ID: 17411738

  • 1. Imaging to optimally stage lung cancer: conventional modalities and PET/CT.
    Truong MT, Munden RF, Movsas B.
    J Am Coll Radiol; 2004 Dec; 1(12):957-64. PubMed ID: 17411738
    [Abstract] [Full Text] [Related]

  • 2. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP, Kramer H, Reiser MF, Glaser C.
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [Abstract] [Full Text] [Related]

  • 3. STIR turbo SE MR imaging vs. coregistered FDG-PET/CT: quantitative and qualitative assessment of N-stage in non-small-cell lung cancer patients.
    Ohno Y, Koyama H, Nogami M, Takenaka D, Yoshikawa T, Yoshimura M, Ohbayashi C, Sugimura K.
    J Magn Reson Imaging; 2007 Oct; 26(4):1071-80. PubMed ID: 17896365
    [Abstract] [Full Text] [Related]

  • 4. Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance.
    Coleman RE, Delbeke D, Guiberteau MJ, Conti PS, Royal HD, Weinreb JC, Siegel BA, Federle MF, Townsend DW, Berland LL, American College of Radiology, Society of Nuclear Medicine, Society of Computed Body Tomography and Magnetic Resonance.
    J Nucl Med; 2005 Jul; 46(7):1225-39. PubMed ID: 16000293
    [Abstract] [Full Text] [Related]

  • 5. Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer.
    Yang W, Fu Z, Yu J, Yuan S, Zhang B, Li D, Xing L, Zhao D, Mu D, Sun X, Fang Y, Huang Y, Li W.
    Lung Cancer; 2008 Jul; 61(1):35-43. PubMed ID: 18177978
    [Abstract] [Full Text] [Related]

  • 6. Can PET/CT replace separate diagnostic CT for cancer imaging? Optimizing CT protocols for imaging cancers of the chest and abdomen.
    Kuehl H, Veit P, Rosenbaum SJ, Bockisch A, Antoch G.
    J Nucl Med; 2007 Jan; 48 Suppl 1():45S-57S. PubMed ID: 17204720
    [Abstract] [Full Text] [Related]

  • 7. Added value of PET and PET-CT in oesophageal cancer: a review of current practice.
    Vinjamuri S, Ray S.
    Nucl Med Commun; 2008 Jan; 29(1):4-10. PubMed ID: 18049091
    [Abstract] [Full Text] [Related]

  • 8. Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities.
    Even-Sapir E.
    J Nucl Med; 2005 Aug; 46(8):1356-67. PubMed ID: 16085595
    [Abstract] [Full Text] [Related]

  • 9. Imaging in the diagnosis and treatment of non-small cell lung cancer.
    Hicks RJ, Lau E, Alam NZ, Chen RY.
    Respirology; 2007 Mar; 12(2):165-72. PubMed ID: 17298447
    [Abstract] [Full Text] [Related]

  • 10. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results.
    Nomori H, Mori T, Ikeda K, Kawanaka K, Shiraishi S, Katahira K, Yamashita Y.
    J Thorac Cardiovasc Surg; 2008 Apr; 135(4):816-22. PubMed ID: 18374761
    [Abstract] [Full Text] [Related]

  • 11. PET/CT for the staging and follow-up of patients with malignancies.
    Poeppel TD, Krause BJ, Heusner TA, Boy C, Bockisch A, Antoch G.
    Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
    [Abstract] [Full Text] [Related]

  • 12. Current state of imaging for lung cancer staging.
    Kent MS, Port JL, Altorki NK.
    Thorac Surg Clin; 2004 Feb; 14(1):1-13. PubMed ID: 15382304
    [Abstract] [Full Text] [Related]

  • 13. [Diagnosis of lung cancer. Role of PET/CT fusion scan in lung cancer].
    Melloni B, Gazaille V, Bertin F, Gaillard S, Monteil J.
    Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S11-16S16. PubMed ID: 17268330
    [Abstract] [Full Text] [Related]

  • 14. How do lung cancer specialists follow their patients with stage III non-small cell lung cancer (NSCLC) after definitive treatment? A short report.
    Yumuk PF, Mohammed N, Maat AP, Fink C, Marchal B, O'Brien ME.
    Eur J Cancer; 2012 Sep; 48(14):2163-5. PubMed ID: 22633748
    [Abstract] [Full Text] [Related]

  • 15. The role of integrated positron emission tomography-computerized tomography in evaluating and staging patients with non-small cell lung cancer.
    Cerfolio RJ, Bryant AS.
    Semin Thorac Cardiovasc Surg; 2007 Sep; 19(3):192-200. PubMed ID: 17983944
    [Abstract] [Full Text] [Related]

  • 16. Bilateral thoracoscopy, mediastinoscopy and laparoscopy, in addition to CT, MRI and PET imaging, are essential to correctly stage and treat patients with mesothelioma prior to trimodality therapy.
    Alvarez JM, Hasani A, Segal A, Sterret G, Millward M, Nowak A, Musk W, Bydder S.
    ANZ J Surg; 2009 Oct; 79(10):734-8. PubMed ID: 19878170
    [Abstract] [Full Text] [Related]

  • 17. Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma.
    Tateishi U, Hosono A, Makimoto A, Nakamoto Y, Kaneta T, Fukuda H, Murakami K, Terauchi T, Suga T, Inoue T, Kim EE.
    Ann Nucl Med; 2009 Feb; 23(2):155-61. PubMed ID: 19225939
    [Abstract] [Full Text] [Related]

  • 18. Integrated fluorine-18 fluorodeoxyglucose (18F-FDG) PET/CT compared to standard contrast-enhanced CT for characterization and staging of pulmonary tumors eligible for surgical resection.
    Quaia E, Tona G, Gelain F, Lubin E, Pizzolato R, Boscolo E, Bussoli L.
    Acta Radiol; 2008 Nov; 49(9):995-1004. PubMed ID: 18651256
    [Abstract] [Full Text] [Related]

  • 19. Screening for cancer with PET and PET/CT: potential and limitations.
    Schöder H, Gönen M.
    J Nucl Med; 2007 Jan; 48 Suppl 1():4S-18S. PubMed ID: 17204716
    [Abstract] [Full Text] [Related]

  • 20. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease.
    Horger M, Bares R.
    Semin Nucl Med; 2006 Oct; 36(4):286-94. PubMed ID: 16950146
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.